Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
for entities : Eli lilly and company save search
Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement
Published: 2024-04-16 (Crawled : 15:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
announcement conference for financial results
Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
Published: 2024-04-11 (Crawled : 05:00) - globenewswire.com
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 1.06%
H: 0.47%
C: -0.03%
fda device disease test granted blood designation for alzheimer's roche
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published: 2024-04-02 (Crawled : 05:00) - prnewswire.com
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -2.79%
H: 1.32%
C: 1.18%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -1.14%
H: 0.02%
C: -1.06%
review cancer treatment advanced china
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published: 2024-04-02 (Crawled : 05:00) - globenewswire.com
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -2.79%
H: 1.32%
C: 1.18%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -1.14%
H: 0.02%
C: -1.06%
HCM | $16.66 -5.66% -6.0% 110K
|
Health Technology
|
| O: 0.21%
H: 1.49%
C: -0.06%
treatment advanced china
Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy
Published: 2024-03-27 (Crawled : 00:00) - prnewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.49%
H: 0.84%
C: -0.07%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
INCY | $53.23 -0.37% -0.38% 1.5M
|
Health Technology
|
| O: -0.09%
H: 1.42%
C: 1.1%
ibi310 first cancer colon therapy study
Academy Award® Winner Matthew McConaughey Narrates MacGillivray Freeman's 3D Documentary for IMAX® and Giant Screen Theaters "Superhuman Body: World of Medical Marvels"
Published: 2024-03-26 (Crawled : 19:00) - prnewswire.com
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.49%
H: 0.84%
C: -0.07%
award world medical
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss
Published: 2024-03-12 (Crawled : 12:00) - globenewswire.com
PFE A | $25.69 -0.85% 0.1% 29M
|
Health Technology
|
| O: -0.21%
H: 0.11%
C: -1.06%
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.9%
H: 2.03%
C: 1.89%
VERU | $1.255 -17.97% -21.91% 3.2M
|
Health Technology
|
| O: -0.53%
H: 2.22%
C: -3.59%
ALT | $7.54 -0.13% -0.13% 2.7M
|
Commercial Services
|
| O: 0.3%
H: 11.41%
C: 9.8%
medical program
Global Angina Pectoris Drugs Market Set for Growth Amid Advancements in Healthcare Infrastructure
Published: 2024-03-11 (Crawled : 23:00) - prnewswire.com
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: 2.01%
H: 0.0%
C: -2.01%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: 0.0%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: 0.02%
H: 0.79%
C: 0.79%
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.9%
H: 2.03%
C: 1.89%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: -0.19%
H: 0.22%
C: -0.21%
global set growth market
FDA Delays Approval of Donanemab for the Treatment of Early-Stage Alzheimer’sAgency to convene an advisory committee to consider the drug
Published: 2024-03-08 (Crawled : 15:30) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: -2.29%
fda drug approval treatment
Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-03-05 (Crawled : 22:00) - prnewswire.com
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.86%
H: 0.45%
C: -0.58%
association cancer research meeting
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Update
Published: 2024-02-28 (Crawled : 21:00) - globenewswire.com
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -0.6%
H: 0.45%
C: 0.08%
MRUS | $40.35 -2.23% -2.28% 820K
|
Health Technology
|
| O: 2.3%
H: 0.58%
C: -2.69%
INCY | $53.23 -0.37% -0.38% 1.5M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -3.07%
business year update financial results
We Don’t Know What We Don’t Know: LGBTQIA+ Patient Data and the Struggle for ...
Published: 2024-02-22 (Crawled : 12:00) - biospace.com/
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 0.59%
H: 1.11%
C: 0.92%
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 2.37%
H: 1.51%
C: 0.79%
We Don’t Know What We Don’t Know: LGBTQIA+ Patient Data and the Struggle for Inclusivity
Published: 2024-02-22 (Crawled : 09:00) - biospace.com/
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 0.59%
H: 1.11%
C: 0.92%
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 2.37%
H: 1.51%
C: 0.79%
Lilly Edges Out J&J to Top 20 BioPharma Market Cap List for 2023
Published: 2024-02-20 (Crawled : 17:00) - biospace.com/
MS 3 d | $89.14 2.47% 0.0% 18M
|
Finance
|
| O: -0.65%
H: 0.64%
C: -0.69%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 1.02%
H: 0.43%
C: -4.35%
biopharma market
Global Tire Recycling Downstream Product Market Set to Reach $5.5 Billion by 2030: Rubber Powder to Lead Market Growth Amid Rising Demand for Repurposed Materials
Published: 2024-02-10 (Crawled : 04:20) - prnewswire.com
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
| Email alert
Add to watchlist
reach repurposed global set growth market
Innovent's First New Drug Application of Mazdutide for Chronic Weight Management has been Accepted by the NMPA of China
Published: 2024-02-07 (Crawled : 09:00) - prnewswire.com
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.76%
H: 4.31%
C: 2.11%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
INCY | $53.23 -0.37% -0.38% 1.5M
|
Health Technology
|
| O: -0.65%
H: 0.57%
C: -3.21%
first management drug application china
Proniras Corporation Secures New Series B Financing and Names New Board Members to Support Phase 1 Study of Novel Treatment for Opiate Withdrawal
Published: 2024-02-01 (Crawled : 22:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.27%
H: 2.04%
C: 2.02%
corporation series treatment study
American Camp Association Receives $45.5 Million Grant from Lilly Endowment Inc. to Strengthen Character Development Programs for Young People at Camp
Published: 2024-02-01 (Crawled : 19:00) - prnewswire.com
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.3%
H: 1.55%
C: 0.8%
association million grant
DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD
Published: 2024-01-30 (Crawled : 09:00) - prnewswire.com
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.11%
H: 0.17%
C: -0.11%
technology potential
Positive Phase 1/2 Clinical Trial Data for an Investigational Gene Therapy for Genetic Hearing Loss to be Presented at the Association for Research in Otolaryngology 2024 MidWinter Meeting
Published: 2024-01-23 (Crawled : 17:00) - prnewswire.com
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -0.51%
H: 0.37%
C: 0.32%
genetic association positive research meeting trial therapy
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.